Works matching DE "NUCLEOSIDE reverse transcriptase inhibitors"
Results: 567
Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 11, p. 3493, doi. 10.1007/s00417-024-06507-9
- By:
- Publication type:
- Article
Replicative co-infections with human immunodeficiency virus 1 and 2 as well as hepatitis B and C virus in Ghanaian individuals.
- Published in:
- European Journal of Microbiology & Immunology, 2024, v. 14, n. 4, p. 346, doi. 10.1556/1886.2024.00103
- By:
- Publication type:
- Article
In vitro effect of some nucleoside reverse transcriptase inhibitors against HSV-1 replication.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 3, p. 1454
- By:
- Publication type:
- Article
Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.
- Published in:
- HIV Medicine, 2018, v. 19, n. 1, p. 18, doi. 10.1111/hiv.12534
- By:
- Publication type:
- Article
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
- Published in:
- HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
- By:
- Publication type:
- Article
An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
- Published in:
- HIV Medicine, 2017, v. 18, n. 5, p. 342, doi. 10.1111/hiv.12435
- By:
- Publication type:
- Article
Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 5, doi. 10.1111/hiv.12386
- By:
- Publication type:
- Article
Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.
- Published in:
- HIV Medicine, 2014, v. 15, n. 7, p. 417, doi. 10.1111/hiv.12129
- By:
- Publication type:
- Article
HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.
- Published in:
- HIV Medicine, 2014, v. 15, n. 4, p. 196, doi. 10.1111/hiv.12100
- By:
- Publication type:
- Article
Subgroup analysis of virological response rates with once- and twice-daily darunavir/ritonavir in treatment-experienced patients without darunavir resistance-associated mutations in the ODIN trial.
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 437, doi. 10.1111/hiv.12024
- By:
- Publication type:
- Article
Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations.
- Published in:
- HIV Medicine, 2013, v. 14, n. 3, p. 176, doi. 10.1111/j.1468-1293.2012.01037.x
- By:
- Publication type:
- Article
5.0 What to start.
- Published in:
- HIV Medicine, 2012, v. 13, p. 28, doi. 10.1111/j.1468-1293.2012.01029_6.x
- Publication type:
- Article
The MONET trial: week 144 analysis of the efficacy of darunavir/ritonavir ( DRV/r) monotherapy versus DRV/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load < 50 HIV-1 RNA copies/ mL at baseline.
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 398, doi. 10.1111/j.1468-1293.2012.00989.x
- By:
- Publication type:
- Article
Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans.
- Published in:
- HIV Medicine, 2012, v. 13, n. 4, p. 193, doi. 10.1111/j.1468-1293.2011.00952.x
- By:
- Publication type:
- Article
Adefovir dipivoxil induces DNA replication stress and augments ATR inhibitor‐related cytotoxicity.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 5, p. 1474, doi. 10.1002/ijc.32966
- By:
- Publication type:
- Article
Pre-treatment HIV-1 drug resistance in Cuban patients with late presentation to health care: 2009-2020.
- Published in:
- Journal of Microbiology & Infectious Diseases, 2024, v. 14, n. 2, p. 60, doi. 10.5455/JMID.2024.v14.i2.4
- By:
- Publication type:
- Article
Boosted- lopinavir versus boosted- atazanavir plus two nucleoside reverse transcriptase inhibitors in second- line antiretroviral therapy in HIV-1 infected patients in Abidjan, Ivory Coast.
- Published in:
- Journal of Microbiology & Infectious Diseases, 2016, v. 6, n. 4, p. 149, doi. 10.5799/jmid.328859
- By:
- Publication type:
- Article
SYNTHESIS, MOLECULAR DOCKING, IN-SILICO ADMET SCREENING, STRUCTURAL SAFETY EVALUATION OF ABACAVIR SULFATE AND ITS NOVEL MODIFIED SUBSTANCE.
- Published in:
- Rasayan Journal of Chemistry, 2023, v. 16, n. 3, p. 1137, doi. 10.31788/RJC.2023.1638335
- By:
- Publication type:
- Article
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LAMIVUDINE IN BULK AND IN TABLET FORMULATION.
- Published in:
- International Journal of Pharmacology & Biological Sciences, 2019, v. 13, n. 3, p. 15
- By:
- Publication type:
- Article
Combination dolutegravir-abacavir-lamivudine in the management of HIV/AIDS: clinical utility and patient considerations.
- Published in:
- Patient Preference & Adherence, 2015, v. 9, p. 299, doi. 10.2147/PPA.S65199
- By:
- Publication type:
- Article
Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
- Published in:
- BMC Research Notes, 2012, v. 5, n. 1, p. 180, doi. 10.1186/1756-0500-5-180
- Publication type:
- Article
Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.
- Published in:
- PLoS ONE, 2024, v. 19, n. 11, p. 1, doi. 10.1371/journal.pone.0314003
- By:
- Publication type:
- Article
Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region.
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0306245
- By:
- Publication type:
- Article
Immunological and molecular assessment of HIV-1 mutations for antiretroviral drug resistance in Saudi Arabia.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304408
- By:
- Publication type:
- Article
Antiviral Medications, Part 2: HIV Antiretroviral Therapy.
- Published in:
- MEDSURG Nursing, 2017, v. 26, n. 5, p. 327
- By:
- Publication type:
- Article
Antiangiogenic VEGF165b Expression in Human Breast MCF-7 and MCF-10A Cells Exposed to Reverse Transcriptase and Protease Inhibitors.
- Published in:
- International Journal of Morphology, 2017, v. 35, n. 1, p. 148, doi. 10.4067/S0717-95022017000100024
- By:
- Publication type:
- Article
Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 9059, doi. 10.3390/ijms25169059
- By:
- Publication type:
- Article
Microglia and p38 MAPK Inhibitors Suppress Development of Mechanical Allodynia in Both Sexes in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 12805, doi. 10.3390/ijms241612805
- By:
- Publication type:
- Article
Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 11144, doi. 10.3390/ijms241311144
- By:
- Publication type:
- Article
Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 5, p. 2727, doi. 10.3390/ijms23052727
- By:
- Publication type:
- Article
Attenuating Diabetic Vascular and Neuronal Defects by Targeting P2rx7.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2101, doi. 10.3390/ijms20092101
- By:
- Publication type:
- Article
Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors—In Silico Activity Prediction.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 3231, doi. 10.3390/ijms19103231
- By:
- Publication type:
- Article
Bictegravir/emtricitabine/tenofovir alafenamide.
- Published in:
- Australian Prescriber, 2019, v. 42, n. 2, p. 68, doi. 10.18773/austprescr.2019.016
- Publication type:
- Article
HIV-1 drug-resistant mutations and related risk factors among HIV-1-positive individuals experiencing treatment failure in Hebei Province, China.
- Published in:
- AIDS Research & Therapy, 2017, v. 14, p. 1, doi. 10.1186/s12981-017-0133-3
- By:
- Publication type:
- Article
Sensory neuropathy and metabolic risk factors in human immune deficiency virus infected South Africans receiving protease inhibitors.
- Published in:
- AIDS Research & Therapy, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12981-015-0073-8
- By:
- Publication type:
- Article
Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques.
- Published in:
- AIDS Research & Therapy, 2014, v. 11, p. 2, doi. 10.1186/1742-6405-11-12
- By:
- Publication type:
- Article
Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure.
- Published in:
- AIDS Research & Therapy, 2012, v. 9, p. 8, doi. 10.1186/1742-6405-9-8
- Publication type:
- Article
Human leucocyte antigen B*57.01 allelic gene is uncommon in Nigerians: An implication for antiretroviral therapy among the HIV/AIDS cohort.
- Published in:
- Indian Journal of Medical Research, 2024, v. 159, n. 5, p. 1, doi. 10.25259/ijmr_1263_23
- By:
- Publication type:
- Article
Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients.
- Published in:
- Indian Journal of Medical Research, 2018, v. 148, n. 2, p. 207, doi. 10.4103/ijmr.IJMR_1144_16
- By:
- Publication type:
- Article
Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 10, p. 1, doi. 10.1002/jmv.29948
- By:
- Publication type:
- Article
Efficacy of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir-based three-drug regimens in people with HIV with varying adherence to antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 281, doi. 10.1093/jac/dkae407
- By:
- Publication type:
- Article
Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 95, doi. 10.1093/jac/dkae377
- By:
- Publication type:
- Article
Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 10, p. 2575, doi. 10.1093/jac/dkae260
- By:
- Publication type:
- Article
The profile of HIV-1 drug resistance in Shanghai, China: a retrospective study from 2017 to 2021.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 526, doi. 10.1093/jac/dkad370
- By:
- Publication type:
- Article
Variable antiviral activity of islatravir against M184I/V mutant HIV-1 selected during antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 370, doi. 10.1093/jac/dkad390
- By:
- Publication type:
- Article
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 339, doi. 10.1093/jac/dkad386
- By:
- Publication type:
- Article
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I.
- Published in:
- 2019
- By:
- Publication type:
- journal article